Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders

Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders

US Patent 7582803 · Granted Sep 1, 2009

Estimated economic value: $115,395,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Substituted pyridine derivatives as SARM1 inhibitors2025
Substituted pyridine derivatives as SARM1 inhibitors2025
Using adiponectin receptor agonists to treat inflammation and bone diseases in d2025
Substituted sulfoximine derivatives2025
Methods of treating neurological disorders2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Fluoroalkyl-oxadiazoles and uses thereof2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Pharmaceutical crystal of contezolid acefosamil, preparation method therefor, an2024
Opioid receptor modulators2024
Substituted pyridine derivatives as SARM1 inhibitors2024